ACURASTEM.COM: Keyword Density Checker

Total words: 1082 | 2-word phrases: 284 | 3-word phrases: 296 | 4-word phrases: 302

PAGE INFO

Title	Try to keep the title under 60 characters (17 characters) Home :: Acurastem
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (26 characters) Patient-Based Therapeutics

#	Keyword	Frequency	Density
1	neurodegenerative disease	5	1.76%
2	read more	3	1.06%
3	» read	3	1.06%
4	about science	2	0.70%
5	annual als	2	0.70%
6	acurastem ceo	2	0.70%
7	new team	2	0.70%
8	to a	2	0.70%
9	development summit	2	0.70%
10	drug development	2	0.70%
11	als drug	2	0.70%
12	at 3rd	2	0.70%
13	3rd annual	2	0.70%
14	clinicalscientific conference	2	0.70%
15	present at	2	0.70%
16	chang to	2	0.70%
17	acurastem a	2	0.70%
18	science therapeutics	2	0.70%
19	2024 acurastem	2	0.70%
20	sam alworth	2	0.70%

#	Keyword	Frequency	Density
1	» read more	3	1.01%
2	about science therapeutics	2	0.68%
3	developed for neurodegenerative	2	0.68%
4	science therapeutics newsevents	2	0.68%
5	present at 3rd	2	0.68%
6	at 3rd annual	2	0.68%
7	3rd annual als	2	0.68%
8	annual als drug	2	0.68%
9	als drug development	2	0.68%
10	drug development summit	2	0.68%
11	for neurodegenerative diseases	2	0.68%
12	new team member	2	0.68%
13	company pioneering how	2	0.68%
14	biotechnology company pioneering	2	0.68%
15	patientbased biotechnology company	2	0.68%
16	blvd suite 220	1	0.34%
17	associate vice president	1	0.34%
18	may 17 2024	1	0.34%
19	17 2024 dr	1	0.34%
20	wenhsuan chang to	1	0.34%
21	chang to present	1	0.34%
22	to present at	1	0.34%
23	2900635 infoacurastemcom ©	1	0.34%
24	213 2900635 infoacurastemcom	1	0.34%
25	91103 213 2900635	1	0.34%
26	ca 91103 213	1	0.34%
27	suite 220 pasadena	1	0.34%
28	acurastem’s associate vice	1	0.34%
29	president dr wenhsuan	1	0.34%
30	vice president dr	1	0.34%

#	Keyword	Frequency	Density
1	about science therapeutics newsevents	2	0.66%
2	developed for neurodegenerative diseases	2	0.66%
3	als drug development summit	2	0.66%
4	patientbased biotechnology company pioneering	2	0.66%
5	biotechnology company pioneering how	2	0.66%
6	annual als drug development	2	0.66%
7	3rd annual als drug	2	0.66%
8	at 3rd annual als	2	0.66%
9	present at 3rd annual	2	0.66%
10	propel neurodegenerative disease research	1	0.33%
11	neurodegenerative disease research acurastem	1	0.33%
12	disease research acurastem a	1	0.33%
13	4th » read more	1	0.33%
14	science therapeutics newsevents patientbased	1	0.33%
15	for neurodegenerative diseases announced	1	0.33%
16	neurodegenerative diseases announced the	1	0.33%
17	diseases announced the expansion	1	0.33%
18	leaders to propel neurodegenerative	1	0.33%
19	announced the expansion of	1	0.33%
20	march 4th » read	1	0.33%
21	on march 4th »	1	0.33%
22	conference on march 4th	1	0.33%
23	its team with three	1	0.33%
24	team with three new	1	0.33%
25	with three new team	1	0.33%
26	three new team members	1	0.33%
27	new team members bringing	1	0.33%
28	team members bringing a	1	0.33%
29	members bringing a fresh	1	0.33%
30	to propel neurodegenerative disease	1	0.33%
31	more ← previous 1	1	0.33%
32	» read more ←	1	0.33%
33	about our work neurodegenerative	1	0.33%
34	conference 2024 acurastem ceo	1	0.33%
35	for patients not limited	1	0.33%
36	patients not limited to	1	0.33%
37	not limited to rare	1	0.33%
38	limited to rare genetically	1	0.33%
39	to rare genetically defined	1	0.33%
40	3 4 5 6	1	0.33%